Journals / Turkish Thoracic Journal / 2018 / Cilt: 19 - Sayı: 3

Factors Affecting Influenza Vaccination Rates among Patients with Chronic Obstructive Pulmonary Disease in Rize, Turkey

Pages
122–126
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Vaccination aganist influenza virus and Streptoccus pneumoniae, the most prevalent agents, is recommended by COPDguidelines.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are major components of COPD-related socioeconomicburden.
📊
Key Findings & Data:The aims of this study were to determine the factors affecting vaccination among patients with COPD and to assess the effectof vaccination status on AECOPD.MATERIALS AND METHODS: Patients with COPD were recruited from the outpatient clinic of a tertiary hospital between December2014 and January 2015.
💡
Conclusion & Impact:Vaccination aganist influenza virus and Streptoccus pneumoniae, the most prevalent agents, is recommended by COPDguidelines.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Özet

OBJECTIVES: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are major components of COPD-related socioeconomicburden. Upper or lower respiratory tract infections, usually caused by respiratory viruses or bacteria, are common causesof AECOPD. Vaccination aganist influenza virus and Streptoccus pneumoniae, the most prevalent agents, is recommended by COPDguidelines. The aims of this study were to determine the factors affecting vaccination among patients with COPD and to assess the effectof vaccination status on AECOPD.MATERIALS AND METHODS: Patients with COPD were recruited from the outpatient clinic of a tertiary hospital between December2014 and January 2015. Demographic data, vaccination status, and COPD-related hospital admissions triggered by tracheobronchialinfections were evaluated.RESULTS: In total, 108 patients were enrolled; 102 (94%) subjects were male, and 6 (6%) subjects were female; the mean age was 65.6years. The number of patients who had received pneumococcal and influenza vaccinations were 8 (0.07%) and 36 (33.3%), respectively.There was no significant correlation between the level of education and vaccination status. No significant difference was found betweentwo groups in terms of exacerbation frequency, hospitalization rates, mMRC scores, and COPD stages.CONCLUSION: More efforts by both physicians and patients are needed to reach the ideal rates of vaccination for COPD.

🔖

Cite This Article

ÖZYURT, S., KARA, B. Y., ÖZÇELİK, N., ŞAHİN, Ü. (2018). Factors Affecting Influenza Vaccination Rates among Patients with Chronic Obstructive Pulmonary Disease in Rize, Turkey. Turkish Thoracic Journal, Cilt: 19 - Sayı: 3, 122–126. https://ajindex.com/articles/418037

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-128. [CrossRef] 2. García-Sanz MT, Cánive-Gómez JC, Senín-Rial L,et al. Oneyear and long-term mortality in patients hospitalized for chronic obstructive pulmonary disease. J Thorac Dis 2017;9:636-45. [CrossRef] 3. Miravitlles M, Anzueto A. Role of infection in exacerbations of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2015;21:278-83. [CrossRef] 4. Mohan A, Chandra S, Agarwal D, et al. Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review. Respirology 2010;15:536- 42. [CrossRef] 5. Montserrat-Capdevila J, Godoy P, et al. [Risk factors for mortality in patients with chronic obstructive pulmonary disease]. Aten Primaria 2015;47:498-504. [Article in Spanish] [CrossRef] 6. Sethi S. Murphy T. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008;359:2355-65. [CrossRef] 7. GOLD (2017)
  2. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. February. Available at: http://www.goldcopd.org. 8. Poole PJ, Chacko E, Wood-Baker R, et al. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006;1:CD002733. [CrossRef] 9. Walters JA, Smith S, Poole P,et al. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2010;11:CD001390. [CrossRef] 10. Hershenson MB. Rhinovirus-Induced Exacerbations of Asthma and COPD, Scientifica (Cairo) 2013;2013:405876. 11. Koul PA., Khan UH., Asad R, et al. Contribution of influenza to acute exacerbations of chronic obstructive pulmonary disease in Kashmir, India, 2010-2012. Influenza Other Respir Viruses 2015;9:40-2. [CrossRef] 12. Joshi M, Chandra D, Mittadodla P, et al. The Impact of Vaccination on Influenza-Related Respiratory Failure and Mortality in Hospitalized Elderly Patients Over the 2013-2014 Season. Open Respir Med J 2015;9:9-14. [CrossRef] 13. Bekkat-Berkani R, Wilkinson T, Buchy P, et al. Seasonal influenza vaccination in patients with COPD: a systematic literature review. BMC Pulm Med 2017;17:79. [CrossRef] 14. Wilkinson TMA, Aris E, Bourne S, et al. A prospective, observational cohort study of the seas